Carbapenem-resistant enterobacteriaceae in children, United States, 1999–2012

Emerging Infectious Diseases

Volumn 21, Issue 11, 2015, Pages 2014-2021

  Logan, Latania K ^a,b   Renschler, John P ^c   Gandra, Sumanth ^c   Weinstein, Robert A ^a,b   Laxminarayan, Ramanan ^c,d,e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Jr Hospital of Cook County   (United States)

^c Center for Disease Dynamics Economics and Policy   (United States)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^e PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CHILD; CITROBACTER; DISEASE SURVEILLANCE; ENTEROBACTER; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PROTEUS MIRABILIS; SCHOOL CHILD; SERRATIA MARCESCENS; UNITED STATES; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENETICS; IMMUNOLOGY; INFANT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGY; TRANSMISSION;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFANT; INTENSIVE CARE UNITS; PREVALENCE; UNITED STATES;

EID: 84944573192     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2111.150548     Document Type: Article

References (38)

1. Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2011;65:455-78. http://dx.doi.org/10.1146/annurev-micro-090110-102911
2. Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54:969-76. http://dx.doi.org/10.1128/AAC.01009-09
3. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56:641-8. http://dx.doi.org/10.1093/cid/cis942
4. Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis. 2015;60:1389-97.
5. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159-66. http://dx.doi.org/10.1016/S1473-3099(08)70041-0
6. Munoz-Price LS, Quinn JP. The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons. Clin Infect Dis. 2009;49:1739-41. http://dx.doi.org/10.1086/ 648078
7. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2
8. Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol. 2013;51:680-3. http://dx.doi.org/10.1128/JCM.02580-12
9. Logan LK. Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012;55:852-9. http://dx.doi.org/10.1093/cid/cis543
10. Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae. Report no. 62, Mar 2013 [cited 2014 Aug 21]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6209a3.htm
11. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, Sep 2013 [cited 2014 Aug 21]. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
12. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother. 2013;57:3012-20. http://dx.doi.org/10.1128/AAC.02252-12
13. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57:1246-52.
14. Braykov NP, Eber M, Klein E, Morgan D, Laxminarayan RM. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010. Infect Control Hosp Epidemiol. 2013;34:259-68. http://dx.doi.org/10.1086/669523
15. Little ML, Qin X, Zerr DM, Weissman SJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int J Antimicrob Agents. 2012;39:52-7. http://dx.doi.org/10.1016/j.ijantimicag.2011.09.014
16. Viau RA, Hujer AM, Marshall SH, Perez F, Hujer KM, Briceno DF, et al. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in northeast Ohio. Clin Infect Dis. 2012;54:1314-21. http://dx.doi.org/10.1093/cid/cis036
17. Hoffmann MS, Eber MR, Laxminarayan R. Increasing resistance of Acinetobacter species to imipenem in United States Hospitals, 1999. Infect Control Hosp Epidemiol. 2010;31:196-7. http://dx.doi.org/10.1086/650379
18. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis. 2009;15:1925-30.
19. Logan LK, Braykov NP, Weinstein RA, Laxminarayan R. Extended-spectrum β-lactamase-producing and third-generation cephalosporin-resistant Enterobacteriaceae in children: trends in the United States, 1999-2011. Journal of the Pediatric Infectious Diseases Society. 2014;3:320-8. http://dx.doi.org/10.1093/jpids/piu010
20. Centers for Disease Control and Prevention. CDC 2012 CRE toolkit: guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) [cited 2014 Jun 25]. http://www.cdc.gov/ hai/organisms/cre/cre-toolkit/background.html
21. R Development Core Team. R: a language and environment for statistical computing, 2013. Vienna: R Foundation for Statistical Computing [cited 2015 Jun 23]. http://www.R-project.org
22. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance: international standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x
23. Falagas ME, Karageorgopoulos DE, Nordmann P. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol. 2011;6:653- 66. http://dx.doi.org/10.2217/fmb.11.49
24. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:60-7. http://dx.doi.org/10.1093/cid/cir202
25. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180-5. http://dx.doi.org/10.1086/648451
26. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099-106. http://dx.doi.org/10.1086/592412
27. Tuon FF, Rocha JL, Toledo P, Arend LN, Dias CH, Leite TM, et al. Risk factors for KPC-producing Klebsiella pneumoniae bacteremia. Braz J Infect Dis. 2012;16:416-9. http://dx.doi.org/10.1016/j.bjid.2012.08.006
28. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, et al. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol. 2010;31:1250-6. http://dx.doi.org/10.1086/657135
29. Hsu AJ, Tamma PD. Treatment of multidrug-resistant gram-negative infections in children. Clin Infect Dis. 2014;58:1439-48. http://dx.doi.org/10.1093/cid/ciu069
30. US Food and Drug Administration. Drug safety and availability. FDA drug safety communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new boxed warning [cited 2014 Sep 10]. http://www.fda.gov/drugs/ drugsafety/ucm369580.htm
31. Haertl R, Bandlow G. Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments. J Clin Microbiol. 1993;31:128-33.
32. Stumpf AN, Roggenkamp A, Hoffmann H. Specificity of enterobacterial repetitive intergenic consensus and repetitive extragenic palindromic polymerase chain reaction for the detection of clonality within the Enterobacter cloacae complex. Diagn Microbiol Infect Dis. 2005;53:9-16. http://dx.doi.org/10.1016/j.diagmicrobio.2005.04.003
33. Miyoshi-Akiyama T, Hayakawa K, Ohmagari N, Shimojima M, Kirikae T. Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae. PLoS ONE. 2013;8:e66358. http://dx.doi.org/10.1371/journal.pone.0066358
34. Viau RA, Kiedrowski L, Perez F, Marchaim D, Guerrero D, Kaye K, et al. K-1676: outbreak analysis of Enterobacter cloacae: hsp60 compares favorably to rep-PCR. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 2014 Sep 8; Washington, DC [cited 2015 Jun 23]. http://www.icaaconline.com/php/icaac2014abstracts/data/ papers/2014/K-1676.htm
35. Stillwell T, Green M, Barbadora K, Ferrelli JG, Roberts TL, Weissman SJ, et al. Outbreak of KPC-3 producing carbapenem-resistant Klebsiella pneumoniae in a US pediatric hospital. Journal of the Pediatric Infectious Diseases Society. 2014;3:1-9.
36. Giuffrè M, Bonura C, Geraci DM, Saporito L, Catalano R, Di Noto S, et al. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect. 2013;85:233-6. http://dx.doi.org/10.1016/j.jhin.2013.08.004
37. Löhr IH, Rettedal S, Natas OB, Naseer U, Oymar K, Sundsfjord A. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother. 2013;68:1043-8. http://dx.doi.org/10.1093/jac/dks502
38. Zerr DM, Qin X, Oron AP, Adler AL, Wolter DJ, Berry JE, et al. Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2014;58:3997-4004. http://dx.doi.org/10.1128/ AAC.02558-14